Skip to main content
Clinical Trials/NL-OMON44588
NL-OMON44588
Completed
N/A

Acute Study to Evaluate a Novel Implantable Midfield Powered Device in Humans with Urinary Incontinence - NSM-001

euSpera Medical Inc.0 sites10 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
overactive bladder syndrome
Sponsor
euSpera Medical Inc.
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
euSpera Medical Inc.

Eligibility Criteria

Inclusion Criteria

  • Patient must be eligible for treatment and indicated for the Medtronic InterStim® system or InterStim® II (implantable pulse generator and lead).
  • Patient wishes to undergo an InterStim® or InterStim® II implant procedure after this acute study.
  • Patient must be in good general health in the opinion of the Investigator.
  • Patient is able to understand and has voluntarily signed and dated the Ethics Committee approved informed consent form prior to initiation of any screening or study\-specific procedures.
  • Patient must be minimum 18 years and maximum 65 years of age.

Exclusion Criteria

  • Patient has any of the contraindications for the InterStim® system or InterStim® II system:
  • o Previous sacral surgery
  • o Neurological conditions
  • o Neurogenic bladder
  • o Neurogenic detrusor over activity
  • o Multiple Sclerosis
  • o Spinal cord injury
  • o Stress urinary incontinence
  • o Primary pelvic pain
  • o Pregnant as determined by urine pregnancy test during screening on the day of the procedure or plan to become pregnant

Outcomes

Primary Outcomes

Not specified

Similar Trials